1. Home
  2. CALX vs AMPH Comparison

CALX vs AMPH Comparison

Compare CALX & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calix Inc

CALX

Calix Inc

HOLD

Current Price

$55.43

Market Cap

4.2B

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$26.45

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALX
AMPH
Founded
1999
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
1.2B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
CALX
AMPH
Price
$55.43
$26.45
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$77.75
$31.00
AVG Volume (30 Days)
832.8K
400.6K
Earning Date
01-28-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.27
Revenue
$933,685,000.00
$723,305,000.00
Revenue This Year
$21.58
$1.35
Revenue Next Year
$13.35
$5.10
P/E Ratio
N/A
$12.04
Revenue Growth
4.89
N/A
52 Week Low
$28.61
$20.39
52 Week High
$71.22
$39.77

Technical Indicators

Market Signals
Indicator
CALX
AMPH
Relative Strength Index (RSI) 48.59 51.27
Support Level $52.72 $25.16
Resistance Level $56.49 $27.44
Average True Range (ATR) 1.67 0.85
MACD 0.36 0.02
Stochastic Oscillator 72.96 48.53

Price Performance

Historical Comparison
CALX
AMPH

About CALX Calix Inc

Calix Inc develops, markets and sells its appliance-based platform, cloud and managed services that enable service providers of all types and sizes to innovate and transform their businesses. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: